Arcus Biosciences (RCUS) Return on Sales Growth (3y) (2020 - 2026)

Arcus Biosciences (RCUS) Return on Sales Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 0.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -76.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 8.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -1.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 3.00
10 Arcus Biosciences 3.74 Bn 3.04 Bn - 0.00

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Mar 31, 2026 -4.00
Dec 31, 2025 -1.00
Sep 30, 2025 -3.00
Jun 30, 2025 1.00
Mar 31, 2025 0.00
Dec 31, 2024 -4.00
Sep 30, 2024 6.00
Jun 30, 2024 6.00
Mar 31, 2024 8.00
Dec 31, 2023 0.00
Sep 30, 2023 -2.00
Jun 30, 2023 23.00
Mar 31, 2023 13.00
Dec 31, 2022 0.00
Sep 30, 2022 11.00
Jun 30, 2022 13.00
Mar 31, 2022 6.00
Dec 31, 2021 28.00
Sep 30, 2021 -6.00